Alembic Pharma Q2 net surges 81% to ₹335 crore
Alembic Pharma reports 81% Q2 profit jump to ₹335 cr on 36% revenue rise, expands DifGen collaboration to boost U.S. growth.
BTC-4.83%
ETH-6.44%
SOL-7.27%
USDC-0.01%
XRP-6.23%
HYPE-9.25%
SUI-9.43%
GRAMTON-7.89%BTC-4.83%ETH-6.44%SOL-7.27%USDC-0.01%XRP-6.23%HYPE-9.25%SUI-9.43%GRAMTON-7.89%BTC-4.83%ETH-6.44%SOL-7.27%USDC-0.01%XRP-6.23%HYPE-9.25%SUI-9.43%GRAMTON-7.89%BTC-4.83%ETH-6.44%SOL-7.27%USDC-0.01%XRP-6.23%HYPE-9.25%SUI-9.43%GRAMTON-7.89%
